[PDF][PDF] 三阴性乳腺癌的新辅助化疗

尹一, 张频 - 临床药物治疗杂志, 2013 - lcywzlzz.com
… (Immunomodulatory), 雄激素受体型 (Luminal androgen receptor) 以及不能分类型 (Unsatable),该…
of breast carcinomas distinguish tumor subclasses with clinical implications[J]. Proc Natl …

[PDF][PDF] 肾母细胞瘤基因1 在卵巢疾病发病机制中的研究进展

刘育昕, 王子晗, 张艺馨, 栾永婕, 孟凯 - 中华诊断学电子杂志 - zhzdxzz.com
… 另外WT1 与 雄激素受体(androgen receptor,AR) 在正常机体中互相制约 维持平衡,在排卵性
PCOS(… The role of WT1 in breast cancer: clinical implications,biological effects and molecular …

肿瘤中ERG 基因的表达及其临床研究进展.

王文君, 於宇, 崔久嵬 - Tianjin Medical Journal, 2019 - search.ebscohost.com
… 雄激 素信号募集雄激素受体(androgen receptor,AR)和拓 扑异构酶Ⅱβ 至TMPRSS2 和ERG
… ERG expression in prostate cancer:biological relevance and clinical implication[J]. J Cancer …

LncRNA 在三阴性乳腺癌诊断和预后中的作用

Q YANG, Y FU, J WANG, H YANG… - Journal of Zhejiang …, 2023 - jzus.zju.edu.cn
: 乳腺癌是一种严重危害女性生命的恶性肿瘤. 乳腺癌患者的预后因分子类型而异, 与其它亚型相
比, 三阴性乳腺癌(TNBC) 因其恶性程度高, 侵袭性强, 进展快, 易复发, 易远处转移, 预后差和死亡…

Mechanism of Chaihu Shugan Powder (柴胡疏肝散) for Treating Depression Based on Network Pharmacology

Y Liu, D Hu, Q Fan, X Zhang, Y Zhu, M Ni… - Chinese journal of …, 2020 - Springer
… Third, although CSP has antidepressant effect in our previous clinical research and
animal model experiment, its mechanism is still unclear and needs further analysis in clinical

[HTML][HTML] 血清睾酮与前列腺癌关系的研究进展

卓涛, 王玉杰, 安恒庆 - Advances in Clinical Medicine, 2023 - hanspub.org
: 前列腺癌(Prostate Cancer, PCa) 发病率在我国呈上升趋势, 睾酮与PCa 密切相关. 过去认为高
的血清睾酮是PCa 的促进因素, 但这一观点正在被逐渐打破, 更多的研究发现治疗前低的血清…

[HTML][HTML] 11 种香豆素类化合物对人膀胱癌细胞系EJ 细胞株生长抑制活性的筛选

杨秀伟, 徐波, 冉福香, 王瑞卿, 吴军… - Journal of Integrative …, 2007 - jcimjournal.com
Objective: To screen antitumor active compounds, drug-like or leading compounds from
Chinese traditional and herbal drugs. Methods: Eleven coumarin compounds isolated from the …

[HTML][HTML] 多囊卵巢综合征患者子代发生的远期改变

S Dan, W Fangfang, Z JIANG… - Journal of Zhejiang …, 2017 - ncbi.nlm.nih.gov
Androgen hypersecretion is one of the main features of PCOS. It has been found that
PCOS has various effects on the offspring in reproductive, metabolic and nervous systems, …

CHIP 蛋白在疾病中的作用研究进展

王韶畅, 代紫璠, 赵林芃, 商瑜 - 北京师范大学学报(自然科学版), 2023 - bnujournal.com
… This review summarizes the role and molecular mechanism of CHIP in cancer and non-malignant
diseases, with implications for clinical treatment and drug development. …

2022 年度前列腺癌基础研究及临床诊疗新进展

潘剑, 朱耀, 戴波, 叶定伟 - 中国癌症杂志, 2023 - china-oncology.com
… Guan等[13]研究发现,抑制CD8+ T细胞的雄 激素受体(androgen receptor,AR)活性可防止 T细胞…
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy …